查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1766202

光療設備市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Phototherapy Equipment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球光療設備市場價值為 6.543 億美元，預計到 2034 年將以 6.6% 的複合年成長率成長，達到 12 億美元。這一上升趨勢主要受皮膚病患病率上升、新生兒黃疸發病率上升以及光療技術的快速創新所推動。白斑症、牛皮癬、痤瘡和濕疹等疾病越來越常見，增加了對光療作為一種非侵入性治療方法的依賴。醫療保健基礎設施的不斷發展，優先考慮改善新生兒和皮膚病的治療，這促進了這些設備的廣泛採用。光療系統的進步，包括基於 LED 的技術、穿戴式解決方案和精確的波長傳輸，使這些治療更安全、更有效，特別是透過最大限度地減少熱暴露和提高用戶舒適度。

光療設備市場 - IMG1

使用特定波段（例如紫外線、紅光或藍光）的設備已顯示出顯著的治療效果，它們能夠觸發靶向生物反應，例如分解新生兒的膽紅素或減少慢性皮膚病的發炎。這些波長經過精心挑選，能夠穿透皮膚的不同深度，從而在不損傷周圍組織的情況下精準治療特定疾病。紫外線尤其適用於治療牛皮癬等自體免疫性皮膚病，因為它可以減緩皮膚細胞過度生長。紅光以其抗炎特性而聞名，有助於組織修復並減少刺激，因此對濕疹和傷口癒合非常有用。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 6.543億美元
預測值 12億美元
複合年成長率 6.6%

2024年，LED系統以3.614億美元的估值領先市場。這些設備因其節能、低發熱量和長使用壽命而備受青睞，尤其對新生兒安全。 LED系統在臨床和家庭環境中的應用日益廣泛，這主要歸功於其便攜性以及在治療白斑、牛皮癬和痤瘡等皮膚病方面取得的顯著療效。 LED解決方案能夠提供可控、精準、均勻的光療，且副作用極小，使其成為醫療保健提供者的首選。

預計到2034年，行動光療設備市場規模將達到7.481億美元。這些行動系統易於使用、操作靈活，並且相容於醫療機構和家庭治療環境。它們在治療新生兒黃疸方面具有顯著的實用性，尤其是因為移動性可以提高治療的可及性和效率。在皮膚科領域，這些攜帶式設備是門診的理想選擇，無需固定安裝即可提供更有針對性的護理。隨著越來越多的患者選擇居家護理解決方案，由於成本節約和便利性，對行動光療設備的需求持續成長。

2024年，美國光療設備市場規模達2.046億美元。美國憑藉其完善的醫療基礎設施、高發生率的皮膚病發病率以及對新生兒治療方案的持續關注，在光療領域佔據著穩固的地位。隨著非侵入性治療的偏好和認知度的提升，光纖系統和先進的LED燈等設備在醫院和家庭護理中的應用日益廣泛。因此，持續的醫療進步以及對患者舒適度和經濟承受能力的日益重視，推動了美國光療設備的需求。

積極影響光療設備市場的關鍵參與者包括 SolRx、Ibis Medical、Natus、Neotech、PHOENIX、GE HealthCare、DAVID、UVBioTek、ATOM MEDICAL、MEDI WAVES、OKUMAN、Phothera、NARANG MEDICAL LIMITED 和 PHILIPS。為了提升影響力，光療設備市場的公司正在大力投資產品創新，專注於 LED 技術、穿戴式光療和提供個人化波長控制的系統。一些參與者正在擴大其全球分銷網路，並與醫院和診所建立策略合作夥伴關係，以擴大客戶群。此外，許多公司正在將物聯網和數位監控功能整合到設備中，以支援遠端護理並改善患者預後。行銷工作強調非侵入性益處和臨床成功，以吸引醫療服務提供者和最終用戶。該公司也專注於緊湊型和家用型號，以滿足對便利且經濟高效的治療解決方案日益成長的需求。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
    • 供應商格局
    • 每個階段的增值
    • 影響價值鏈的因素
  • 產業衝擊力
    • 成長動力
      • 新生兒黃疸盛行率上升
      • 日益嚴重的皮膚病
      • 光療設備的技術進步
      • 政府對新生兒護理的支持舉措
    • 產業陷阱與挑戰
      • 替代療法的可用性
      • 產品成本高，低度開發地區取得管道有限
    • 機會
      • 家庭醫療保健的興起趨勢
      • 採用智慧光療設備
  • 成長潛力分析
  • 監管格局
    • 北美洲
    • 歐洲
  • 技術和創新格局
    • 當前的技術趨勢
    • 新興技術
  • 按產品分類的價格趨勢
  • 未來市場趨勢
  • 報銷場景
    • 報銷政策對市場成長的影響
  • 消費者行為分析
  • 差距分析
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
    • 全球的
    • 北美洲
    • 歐洲
    • 世界其他地區
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 關鍵進展
    • 併購
    • 夥伴關係和合作
    • 新產品發布
    • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 年至 2034 年

  • 主要趨勢
  • 基於LED
  • 傳統的
  • 光纖

第6章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 皮膚病治療
  • 新生兒黃疸管理
  • 其他應用

第7章：市場估計與預測：按模式，2021 年至 2034 年

  • 主要趨勢
  • 移動的
  • 固定的
  • 穿戴

第8章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院和診所
  • 居家護理

第9章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • ATOM MEDICAL
  • DAVID
  • GE HealthCare
  • Ibis Medical
  • MEDI WAVES
  • NARANG MEDICAl LIMITED
  • natus
  • Neotech
  • OKUMAN
  • PHILIPS
  • PHOENIX
  • Phothera
  • SolRx
  • UVBioTek
簡介目錄
Product Code: 14111

The Global Phototherapy Equipment Market was valued at USD 654.3 million in 2024 and is estimated to grow at a CAGR of 6.6% to reach USD 1.2 billion by 2034. This upward trend is primarily driven by the increasing prevalence of skin-related ailments, rising incidences of neonatal jaundice, and rapid innovation in phototherapy technologies. Conditions like vitiligo, psoriasis, acne, and eczema are becoming more common, increasing the reliance on phototherapy as a non-invasive treatment method. The widespread adoption of these devices is reinforced by the growing healthcare infrastructure that prioritizes improved treatment for newborns and dermatological conditions. Advancements in phototherapy systems, including LED-based technology, wearable solutions, and precision wavelength delivery, have made these treatments safer and more effective, particularly by minimizing heat exposure and enhancing user comfort.

Phototherapy Equipment Market - IMG1

Devices using specific bands of light, such as UV, red, or blue, have shown significant therapeutic effects by triggering targeted biological responses, such as bilirubin breakdown in newborns or inflammation reduction in chronic skin diseases. These wavelengths are carefully selected to penetrate the skin at varying depths, allowing for precise treatment of specific conditions without damaging surrounding tissue. UV light is particularly effective in managing autoimmune skin disorders like psoriasis by slowing down excessive skin cell growth. Red light, known for its anti-inflammatory properties, supports tissue repair and reduces irritation, making it useful for eczema and wound healing.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$654.3 Million
Forecast Value$1.2 Billion
CAGR6.6%

In 2024, LED-based systems led the market with a valuation of USD 361.4 million. These devices are favored for their energy efficiency, low heat output, and extended operational life, making them particularly safe for neonates. Their growing use in both clinical and home settings is largely due to their portability and proven outcomes in treating dermatological disorders like vitiligo, psoriasis, and acne. The ability to deliver controlled, precise, and uniform light therapy with minimal side effects is positioning LED-based solutions as a preferred choice among healthcare providers.

The mobile phototherapy device segment is projected to reach USD 748.1 million by 2034. These mobile systems offer ease of use, operational flexibility, and compatibility with both healthcare facilities and at-home treatment environments. Their utility in treating neonatal jaundice is significant, particularly because mobility enhances treatment accessibility and efficiency. In the field of dermatology, these portable units are ideal for outpatient clinics, enabling more targeted care without requiring fixed installations. As more patients opt for home-based care solutions, the demand for mobile phototherapy equipment continues to climb due to cost savings and convenience.

U.S. Phototherapy Equipment Market accounted for USD 204.6 million in 2024. The country maintains a strong foothold in the phototherapy space due to its well-developed healthcare infrastructure, high prevalence of skin conditions, and continued focus on neonatal treatment solutions. Devices such as fiber optic systems and advanced LED units are increasingly utilized in both hospital settings and home care, supported by a rise in non-invasive treatment preferences and heightened awareness. As a result, demand in the U.S. is fueled by consistent medical advancements and the growing emphasis on patient comfort and affordability.

Key players actively shaping the Phototherapy Equipment Market include SolRx, Ibis Medical, Natus, Neotech, PHOENIX, GE HealthCare, DAVID, UVBioTek, ATOM MEDICAL, MEDI WAVES, OKUMAN, Phothera, NARANG MEDICAL LIMITED, and PHILIPS. To enhance their presence, companies in the phototherapy equipment market are investing heavily in product innovation, focusing on LED technology, wearable light therapy, and systems offering personalized wavelength control. Several players are expanding their global distribution networks and entering strategic partnerships with hospitals and clinics to broaden their customer base. Additionally, many are integrating IoT and digital monitoring capabilities into devices to support remote care and improve patient outcomes. Marketing efforts emphasize non-invasive benefits and clinical success to attract both healthcare providers and end-users. Companies are also focusing on compact and home-use models to cater to the increasing demand for convenient and cost-effective therapy solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product type
    • 2.2.3 Application
    • 2.2.4 Modality
    • 2.2.5 End Use
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Value addition at each stage
    • 3.1.3 Factor affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of neonatal jaundice
      • 3.2.1.2 Growing skin disorders
      • 3.2.1.3 Technological advancements in phototherapy devices
      • 3.2.1.4 Supportive government initiatives for newborn care
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Availability of alternative treatments
      • 3.2.2.2 High product cost and limited accessibility in underdeveloped regions
    • 3.2.3 Opportunities
      • 3.2.3.1 Rising trend of home healthcare
      • 3.2.3.2 Adoption of smart phototherapy devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Price trends, by product
  • 3.7 Future market trends
  • 3.8 Reimbursement scenario
    • 3.8.1 Impact of reimbursement policies on market growth
  • 3.9 Consumer behaviour analysis
  • 3.10 Gap analysis
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 Global
    • 4.2.2 North America
    • 4.2.3 Europe
    • 4.2.4 Rest of the world
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 LED-based
  • 5.3 Conventional
  • 5.4 Fiberoptic

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Skin disease treatment
  • 6.3 Neonatal jaundice management
  • 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By Modality, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Mobile
  • 7.3 Fixed
  • 7.4 Wearable

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Homecare

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ATOM MEDICAL
  • 10.2 DAVID
  • 10.3 GE HealthCare
  • 10.4 Ibis Medical
  • 10.5 MEDI WAVES
  • 10.6 NARANG MEDICAl LIMITED
  • 10.7 natus
  • 10.8 Neotech
  • 10.9 OKUMAN
  • 10.10 PHILIPS
  • 10.11 PHOENIX
  • 10.12 Phothera
  • 10.13 SolRx
  • 10.14 UVBioTek